Keywords: Dainippon Sumitomo Pharma, Singapore, Subsidiary, Sunovion, Business expansion Asia-Pacific

Dainippon Sumitomo sets up subsidiary in Singapore

Article | 21 January 2013

Print This

Japanese drug major Dainippon Sumitomo Pharma (TYO: 4506) has established a wholly-owned subsidiary in Singapore as a base for operations in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in